2. Gene
  3. CRBN - cereblon Gene

CRBN - cereblon Gene

  • 基因
  • 蛋白
  • 疾病
  • 相关产品
  • 直系同源

中文名称：大脑

种属: Homo sapiens

同用名: MRT2; MRT2A

基因 ID: 51185 | 基因类型: protein coding

关于 CRBN

Cytogenetic location: 3p26.2 Genomic coordinates (GRCh38): 3:3,149,633-3,179,717 (from NCBI)

This gene has 14 transcripts (splice variants), 207 orthologues and is associated with 3 phenotypes. Ubiquitous expression in testis (RPKM 17.6), brain (RPKM 16.5) and 25 other tissues.

功能概要

该基因编码与 Lon 蛋白酶蛋白家族相关的蛋白质。在啮齿类动物和其他哺乳动物中，这种基因产物存在于细胞质中，钙通道膜蛋白定位于此，并被认为在大脑发育中发挥作用。该基因的突变与常染色体隐性非综合征性认知障碍有关。已发现该基因编码不同异构体的多个转录变体。[RefSeq 提供，2010 年 3 月]

This gene encodes a protein related to the Lon protease protein family. In rodents and Other mammals this gene product is found in the cytoplasm localized with a Calcium Channel membrane protein, and is thought to play a role in brain development. Mutations in this gene are associated with autosomal recessive nonsyndromic cognitive disability. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2010]

CRBN 基因产物(4)

mRNA Protein Name
NM_001173482.1 NP_001166953.1 protein cereblon isoform 2
NM_016302.4 NP_057386.2 protein cereblon isoform 1
NM_001173482.1 NP_001166953.1 protein cereblon isoform 2
NM_016302.4 NP_057386.2 protein cereblon isoform 1
基因本体论
  • 分子功能
  • 生物过程
  • 细胞组分
分子功能 GO 注释 逻辑证据 参考文献 来源
enables protein binding IPI
IPI: 通过物理相互作用推断
20223979 GOA
生物过程 GO 注释 逻辑证据 参考文献 来源
involved in positive regulation of Wnt signaling pathway IMP
IMP: 通过突变表型推断
34489457 GOA
involved in proteasome-mediated ubiquitin-dependent protein catabolic process IMP
IMP: 通过突变表型推断
20223979 GOA
involved in protein ubiquitination IMP
IMP: 通过突变表型推断
20223979 GOA
细胞组分 GO 注释 逻辑证据 参考文献 来源
part of Cul4A-RING E3 ubiquitin ligase complex IDA
IDA: 通过直接分析推断
20223979 GOA
located in cytoplasm IDA
IDA: 通过直接分析推断
20223979 GOA
located in nucleus IDA
IDA: 通过直接分析推断
20223979 GOA
EXP：通过实验结果推断 IDA：通过直接分析推断 IPI：通过物理相互作用推断 IMP：通过突变表型推断 IGI：通过遗传相互作用推断 IEP：通过表达模式推断

CRBN 蛋白结构

LON_substr_bdg

LON_substr_bdg: ATP-dependent protease La (LON) substrate-binding domain (80 - 317)

  • 0
  • 100
  • 200
  • 300
  • 400
  • 442 a.a.
蛋白主名 其他名称

protein cereblon

protein x 0001

CRBN 蛋白互作信息

分类
蛋白名称 蛋白编号 互作蛋白 互作蛋白种属 互作蛋白编号 实验方法 参考文献
种属内
CRBN Q96SW2 CSNK1A1 Homo sapiens P48729
X-Ray Diffraction
26909574
种属内
CRBN Q96SW2 CSNK1A1 Homo sapiens P48729
Anti Bait CoIP
26131937
种属内
CRBN Q96SW2 CSNK1A1 Homo sapiens P48729
Anti Tag CoIP
26131937
种属内
CRBN Q96SW2 DDB1 Homo sapiens Q16531
X-Ray Diffraction
26909574
种属内
CRBN Q96SW2 DDB1 Homo sapiens Q16531
Anti Bait CoIP
26131937
种属内
CRBN Q96SW2 PMP22 Homo sapiens A0A6Q8PF08
Validated Y2H
32814053
种属内
CRBN Q96SW2 PMP22 Homo sapiens A0A6Q8PF08
Y2H Array
32814053
种属内
CRBN Q96SW2 PMP22 Homo sapiens A0A6Q8PF08
Y2H Pooling
32814053
种属内
CRBN Q96SW2 PAK5 Homo sapiens Q9P286
Y2H Array
31515488
种属内
CRBN Q96SW2 PAK5 Homo sapiens Q9P286
Validated Y2H
25416956
种属内
CRBN Q96SW2 PAK5 Homo sapiens Q9P286
Y2H Array
25416956
种属间: 跨种属相互作用 种属内: 同种属相互作用

CRBN 抗体

目录号 产品名 应用 反应物种
HY-P86823 CRBN Antibody (YA6516) WB, IHC-P, IP Human, Mouse, Rat

关联疾病

疾病名称 别名
Intellectual Developmental Disorder, Autosomal Recessive 2

Mental Retardation, Autosomal Recessive 2a

MRT2

Mental Retardation, Autosomal Recessive 2

Mrt2a

Autosomal Recessive Intellectual Developmental Disorder 2

Mental Retardation, Autosomal Recessive, Type 2
Autosomal Recessive Non-Syndromic Intellectual Disability

Ar-Nsid

Ns-Arid
Plasma Cell Neoplasm

Plasma Cell Dyscrasia

Paraproteinemias

Plasma Cell Tumour

Plasmacytic Tumor

Multiple Myeloma

Plasmacytoma

Plasma Cell Tumours

Plasma Cells Dyscrasia
Myeloma, Multiple

Multiple Myeloma

Plasma Cell Myeloma

Kahler Disease

Myelomatosis

Medullary Plasmacytoma

Multiple Myeloma, Resistance To

Myeloma

Plasma Cell Dyscrasia

Kahler'S Disease

Multiple Myeloma, Susceptibility To

Myeloma - Multiple

Kahler-Bozzolo Disease

Plasma Cell Myelomas

MM

Plasma Cell Neoplasm

Primary Systemic Amyloidosis

Primary Amyloidosis

Immunoglobulin Deposition Disease

Plasmacytic Myeloma

Multiple Myelomata

Multiple Myeloma Nos

Multiple Myeloma Without Mention Of Remission

Monostotic Plasma Cell Myeloma

Mm - [Multiple Myeloma]
Erythema Nodosum
Duane-Radial Ray Syndrome

Okihiro Syndrome

DRRS

Dr Syndrome

Duane Anomaly With Radial Ray Abnormalities And Deafness

Acrorenoocular Syndrome

Acrorenocular Syndrome

Duane Anomaly With Radial Abnormalities And Deafness

Acro-Renal-Ocular Syndrome
Chromosome 3pter-P25 Deletion Syndrome

3p- Syndrome

3p Deletion Syndrome

Distal Monosomy 3p

Chromosome 3, Monosomy 3p

3p Partial Monosomy Syndrome

Chromosome 3, Deletion 3p

Chromosome 3p Deletion Syndrome

Del Syndrome

Deletion 3p

Monosomy 3p

Partial Monosomy 3p

Distal 3p Deletion

Monosomy 3pter

Telomeric Monosomy 3p

Chromosome Deletion Syndrome 3pter-P25
Autosomal Recessive Intellectual Developmental Disorder

Mental Retardation, Autosomal Recessive

Autosomal Recessive Mental Retardation

Autosomal Recessive Non-Syndromic Mental Retardation

Autosomal Recessive Non-Syndromic Intellectual Disability
Non-Secretory Myeloma
Smoldering Myeloma
Bone Marrow Cancer

Malignant Neoplasm Of Bone Marrow

Bone Marrow Neoplasm

Bone Marrow Tumor

Malignant Bone Marrow Tumor

Myeloproliferative Disorders

Bone Marrow Neoplasms

Myeloproliferative Disease

Chronic Myeloproliferative Disorder
Monoclonal Gammopathy Of Uncertain Significance

Monoclonal Gammopathy Of Undetermined Significance

Mgus

Mgus - [Monoclonal Gammopathy Of Undetermined Significance]

Monoclonal Gammopathy Nos

Iga Gammopathy

Monoclonal Gammoglobulinopathy
Thrombocytopenia

Low Platelet Count

Low Platelets

Decreased Platelets

Platelet Dysfunction Nos
Leukocyte Disease

Leukocyte Disorders
Leprosy 3

Leprosy

Leprosy, Susceptibility To, 3

Hansen'S Disease

Leprosy, Susceptibility To

Hansen Disease

Infection Due To Mycobacterium Leprae

LPRS3

Leprosy, Type 3

Anaesthesia Leprosy

Anaesthetic Leprosy

Maculoanaesthetic Leprosy

Macular Leprosy

Leprosy Unspecified
Mantle Cell Lymphoma

Lymphoma, Mantle Cell

Lcm

Mcl

Mantle Zone Lymphoma

Lymphoma Mantle-Cell

Lymphoma, Mantle-Cell

Malignant Lymphoma, Lymphocytic, Intermediate Differentiation, Diffuse

Malignant Lymphoma - Lymphocytic, Intermediate Differentiation

Diffuse Small Cleaved-Cell Lymphoma

Diffuse Small Cleaved Cell Malignant Lymphoma

Small Cleaved Cell Non-Hodgkin Lymphoma

Diffuse Non-Hodgkin Small Cleaved Cell Lymphoma

Malignant Lymphomatous Polyposis

Malignant Small Cell, Noncleaved, Diffuse Lymphoma

Malignant Undifferentiated Cell, Non-Burkitt Lymphoma

Cleaved Cell Lymphoma

Small Cell Mantle Cell Lymphoma

Small Cleaved Cell Malignant Lymphoma
Myelodysplastic Syndrome

Myelodysplastic Syndromes

Myelodysplasia

MDS

Myelodysplastic Syndrome Included

Myelodysplastic Syndrome, Susceptibility To, Included

Myelodysplastic Syndrome, Somatic

Myelodysplastic Syndrome, Susceptibility To
Leukemia, Acute Myeloid

Acute Myeloid Leukemia

Leukemia, Acute Myelogenous

Acute Myelogenous Leukemia

AML

Leukemia, Acute Myeloid, Susceptibility To

Acute Myeloblastic Leukemia

Leukemia, Acute Myeloid, Reduced Survival In, Somatic

Acute Myeloid Leukaemia

Leukemia, Myelocytic, Acute

Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome

Secondary Aml

Acute Myelocytic Leukemia

Acute Myeloid Leukemia, Somatic

Leukemia, Acute Myeloid, Somatic

Myeloid Leukemia, Acute, M4/M4eo Subtype, Somatic

Acute Myeloblastic Leukaemia

Acute Myelogenous Leukaemia

Aml - Acute Myeloid Leukemia

Acute Myeloid Leukemia With Cebpa Somatic Mutations

Aml With Cebpa Somatic Mutations

Inherited Acute Myeloid Leukemia

Familial Aml

Inherited Aml

Pure Familial Aml

Pure Familial Acute Myeloid Leukemia

Secondary Acute Myeloid Leukemia

Therapy-Related Aml And Myelodysplastic Syndrome

Acute Myeloid Leukemia, Secondary

Acute Non-Lymphoblastic Leukemia

Acute Non-Lymphocytic Leukemia

Acute Biphenotypic Leukemia

Acute Undifferentiated Leukemia

Acute Myeloblastic Leukaemia With Multilineage Dysplasia

Acute Myeloid Leukaemia With Multilineage Dysplasia Without Mention Of Remission

Acute Myeloid Leukaemia With Myelodysplasia-Related Features
疾病名称 别名
Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

相关产品

Approval
生物活性分子 (4)
目录号 产品名 作用方式
纯度 是否罕见病
HY-A0003 Lenalidomide Inducer 99.95% 是
HY-14658 Thalidomide Inducer 99.98% 是
HY-A0003B Lenalidomide hemihydrate Inducer 99.98% 是
HY-A0003A Lenalidomide hydrochloride / 否
Clinical Phase
生物活性分子 (8)
目录号 产品名 作用方式
纯度 Phase
HY-158101 BMS-986365 Degrader 99.92% Phase 3
HY-115997 PROTAC HSP90 degrader BP3 Inhibitor 99.54% Phase 3
HY-130800 Eragidomide 99.93% Phase 2
HY-146237 Golcadomide Modulator 98.04% Phase 2
HY-137465 CG428 Degrader 98.26% Phase 2
HY-145925B CFT8634 Inhibitor 98.10% Phase 1
HY-145776 ALV1 Inhibitor 98.62% Phase 1
HY-W1008736 CRBN ligand-287 / Phase 1
Pre-clinical Phase
生物活性分子 (946)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-114421 FKBP12 PROTAC dTAG-13 Degrader 99.89% 否
HY-101488 CC-885 99.26% 否
HY-101291 Iberdomide Inducer 99.54% 是
HY-160695 PT-179 99.91% 否
HY-12214A NVP-2 99.05% 否
HY-134582 dCBP-1 Inhibitor 99.37% 否
HY-163410 AU-24118 Degrader 99.10% 否
HY-132199 SJ6986 Degrader 98.35% 否
HY-144998 NVP-DKY709 Inhibitor 99.66% 否
HY-148333 MS177 99.55% 否
HY-153321 Bexobrutideg Degrader 99.33% 否
HY-129603 SI-109 Inhibitor 99.91% 否
HY-123937 THAL-SNS-032 Inhibitor 97.11% 否
HY-147098 dTAG-47 Degrader 99.65% 否
HY-155008 PROTAC HK2 Degrader-1 Degrader 98.98% 否
HY-W077589 Lenalidomide-5-aminomethyl hydrochloride 98.45% 否
HY-153341 Tagarafdeg Degrader 99.41% 否
HY-130665 TL12-186 Inhibitor 99.63% 否
HY-41547 Thalidomide 4-fluoride Inducer 99.92% 否
HY-103597 Thalidomide-O-COOH 99.85% 否
HY-158113 CBPD-409 Degrader 99.38% 否
HY-133120 INY-03-041 Inhibitor 99.74% 否
HY-145765 JQAD1 98.24% 否
HY-156698 HJM-561 Degrader 99.26% 否
HY-139344 FC-11 Degrader 99.95% 否
HY-157839 PROTAC α-Synuclein/Tau degrader 1 Degrader 99.28% 否
HY-W593975 CRBN ligand-547 99.82% 否
HY-141881 PROTAC-O4I2 99.56% 否
HY-123941 FKBP12 PROTAC dTAG-7 Inhibitor 99.47% 否
HY-137206 ALV2 98.05% 否
HY-23095 Thalidomide-5-OH Inducer 98.23% 否
HY-151902 SJ988497 99.03% 否
HY-172162 LC-04-045 99.56% 否
HY-131717 Thalidomide-NH-CH2-COOH Inducer 98.07% 否
HY-163814 CDK2 degrader 1 Degrader 99.74% 否
HY-24538 CRBN ligand-880 99.96% 否
HY-150608 PROTAC STING Degrader-1 Inhibitor 98.26% 否
HY-161574 LLC0424 Inhibitor 98.42% 否
HY-175749 BMS-986463 Degrader 95.46% 否
HY-145696 SJ10542 Inhibitor 99.32% 否
HY-125876 PROTAC Bcl2 degrader-1 Inhibitor 99.80% 否
HY-103596 Thalidomide-4-OH Inducer 99.85% 否
HY-114420 AP1867-2-(carboxymethoxy) Inhibitor 99.88% 否
HY-122562 MT-802 Degrader 98.35% 否
HY-149845 PROTAC GSK-3β Degrader-1 Degrader 99.05% 否
HY-173523 KI-CDK9d-32 98.99% 否
HY-W440247 CRBN ligand-109 99.11% 否
HY-136262 CRBN-6-5-5-VHL Degrader 99.45% 否
HY-43722 Lenalidomide-Br 99.86% 否
HY-130504 Propargyl-PEG1-acid 97.0% 否
HY-W442918 CRBN ligand-881 99.30% 否
HY-126534A Abemaciclib metabolite M18 hydrochloride Inhibitor 98.18% 否
HY-175742 BMS-986470 Degrader 99.78% 否
HY-14658A (S)-Thalidomide Inducer 99.52% 否
HY-153166 PT-65 99.48% 否
HY-145282 MS170 Inhibitor 98.68% 否
HY-145152 Biotin-Thalidomide Inducer 99.45% 否
HY-147158 ZXH-1-161 98.43% 否
HY-W440230 5,6-Difluoro-desamino lenalidomide / 否
HY-153803 GBD-9 Degrader 99.91% 否
HY-148369 U7D-1 99.68% 否
HY-156591 PROTAC MLKL Degrader-1 Degrader 99.76% 否
HY-111594 Homo-PROTAC cereblon degrader 1 99.66% 否
HY-131318 Lenalidomide-I 99.84% 否
HY-149843 LC-MB12 99.23% 否
HY-W244657 3-(6-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione 98.77% 否
HY-132857A ZXH-4-130 TFA 99.71% 否
HY-168593 PROTAC KDM3 degrader-1 99.07% 否
HY-W072954 Lenalidomide-5-Br 99.87% 否
HY-157570 Anti-inflammatory agent 70 Degrader 97.00% 否
HY-W1004786 CRBN ligand-13 97.94% 否
HY-128845 PROTAC CRBN Degrader-1 Degrader 98.77% 否
HY-133137 SJF620 Inhibitor 98.98% 否
HY-133557 XZ739 99.08% 否
HY-130988 Ipatasertib-NH2 99.64% 否
HY-139186 PROTAC KRAS G12C degrader-1 Degrader 99.15% 否
HY-176134 RP03707 Degrader 98.00% 否
HY-43983 CRBN ligand-798 96.93% 否
HY-W243100 5-Br-6-F-Desamino lenalidomide / 否
HY-158239 MS181 Inhibitor 98.36% 否
HY-126457 Thalidomide-propargyl Inducer 99.97% 否
HY-144995 BSJ-02-162 Inhibitor 98.07% 否
HY-147099 dTAG-47-NEG 97.8% 否
HY-161128 Lenalidomide 4'-PEG1-amine dihydrochloride 98.42% 否
HY-161536 PROTAC EGFR degrader 9 98.35% 否
HY-171139 PROTAC HDAC6 degrader 2 Inhibitor 99.80% 否
HY-173154B NK7-902 diTFA 99.88% 否
HY-W093472 Desamino lenalidomide-6-COOH 98.45% 否
HY-W598447 CRBN ligand-734 / 否
HY-114406 TD-106 99.81% 否
HY-133144 Lenalidomide-OH 99.48% 否
HY-130714 TD-165 Inhibitor 98.08% 否
HY-126534 Abemaciclib metabolite M18 Inhibitor 98.01% 否
HY-147858 PROTAC EGFR degrader 7 99.99% 否
HY-150839 E3 ligase Ligand PG 99.94% 否
HY-158045 PROTAC PARP1 degrader-1 Inhibitor 99.86% 否
HY-161233A BTX-6654 formate 98.85% 否
HY-163815 CDK2 degrader 2 Degrader 99.51% 否
HY-173414 PROTAC STING degrader-3 98.04% 否
HY-W093272 Thalidomide-5,6-F Inducer 99.84% 否
HY-W584677 Desamino lenalidomide-CH2NH2 hydrochloride ≥95.0% 否
HY-115881 SR-1114 Degrader 99.04% 否
HY-122725B Lenalidomide-C5-NH2 hydrochloride 99.28% 否
HY-122653A CCT367766 formic 98.10% 否
HY-133120A INY-03-041 trihydrochloride Inhibitor 99.78% 否
HY-114407 TD-428 Inhibitor 98.81% 否
HY-123324 Pomalidomide-5-OH 99.46% 否
HY-130296 Palbociclib-propargyl 96.12% 否
HY-138881 Lenalidomide-6-F 99.63% 否
HY-139539 Thalidomide-5-COOH Inducer 99.94% 否
HY-163757 PROTAC PD-L1 degrader-1 Inhibitor 99.79% 否
HY-173266A TO-1187 TFA Degrader 98.41% 否
HY-173357 TYD-68 99.54% 否
HY-W076696 3-(4-Hydroxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione 98.57% 否
HY-132226 Desamino lenalidomide-5-F / 否
HY-W998293 CRBN ligand-397 / 否
HY-130737 Pomalidomide 4'-alkylC5-acid 98.78% 否
HY-115446A Lenalidomide-C4-NH2 hydrochloride 95.84% 否
HY-137342 SB1-G-187 Degrader 98.70% 否
HY-148290 KTX-951 Degrader 99.60% 否
HY-149862 ARD-2051 Degrader 98.57% 否
HY-150616 SJPYT-195 Inhibitor 99.41% 否
HY-160241 Lenalidomide-C5-acid 96.36% 否
HY-161129 Lenalidomide 4'-PEG2-amine dihydrochloride 98.96% 否
HY-161633 PROTAC EGFR degrader 11 Degrader 99.20% 否
HY-W129872 Thalidomide-5-CH2-NH2 hydrochloride Inducer 98.55% 否
HY-W145436 Thalidomide-Piperazine 5-fluoride hydrochloride Inducer 98.91% 否
HY-W259932 Lenalidomide 5'-piperazine hydrochloride 99.92% 否
HY-W249500 2-Methoxyphenyl dihydrouracil 95.11% 否
HY-W886316 CRBN ligand-394 99.77% 否
HY-130683 Lenalidomide-propargyl-C2-NH2 hydrochloride 98.01% 否
HY-112811 PROTAC CDK9 degrader-2 Inhibitor 99.22% 否
HY-123215 CC-17369 98.68% 否
HY-130713 Thalidomide-C2-amido-C2-COOH Inducer 98.45% 否
HY-130716 Thalidomide-NH-C10-COOH Inducer 97.50% 否
HY-151071 TMX-3013 Inhibitor 98.02% 否
HY-155262 Pomalidomide-5-C6-NH2 hydrochloride 98.46% 否
HY-174444A PROTAC HDAC degrader-2 TFA Degrader 95.70% 否
HY-178861 dCDK9-202 99.25% 否
HY-43941 Thalidomide-NH-C5-NH2 TFA / 否
HY-W244728 Desamino lenalidomide-pinacolborane ≥98.0% 否
HY-W460201 CRBN ligand-660 / 否
HY-W575237 Desamino lenalidomide-NO2 99.76% 否
HY-W576870 Hydrouracil-3-Ph-COOH / 否
HY-W898989 3-(4-Bromo-2-chlorophenyl)piperidine-2,6-dione 98.92% 否
HY-129608 Lenalidomide-acetylene-C5-COOH 99.26% 否
HY-130952 Thalidomide-O-C8-COOH Inducer 97.44% 否
HY-130991 K-Ras ligand-Linker Conjugate 6 / 否
HY-131232 Desmorpholinyl Navitoclax-NH-Me Inhibitor 98.64% 否
HY-136688 MI-389 99.34% 否
HY-138040 CRBN modulator-1 98.00% 否
HY-161741 VinclozolinM2-2204 Degrader 98.00% 否
HY-168615 MGD-28 Degrader 99.73% 否
HY-169989 CRBN ligand-11 99.94% 否
HY-172931 DEG-35 Degrader 98.88% 否
HY-173097 (S,R,S)-AHPC-Boc derivative 1 Degrader 98.56% 否
HY-173679 RBN012811 98.79% 否
HY-174864 JP-163-16 96.61% 否
HY-174876 PZ671 / 否
HY-175839 PROTAC EGFR degrader 15 99.23% 否
HY-176428 PROTAC MNK1 degrader-1 98.09% 否
HY-176857 PROTAC STAT6 degrader-1 Degrader / 否
HY-W584518 Thalidomide-5-O-CH2-COOH Inducer 95.02% 否
HY-W593794 E3 ligase Ligand 79 99.07% 否
HY-W998345 SMART1 Inhibitor 99.87% 否
HY-164891 EM12-FS 98.4% 否
HY-W251343 Desamino lenalidomide-6-OH / 否
HY-W452760 Glutarimide-(1-oxoisoindoline-5-carbaldehyde) / 否
HY-W593978 CRBN ligand-395 / 否
HY-W594189 Desamino lenalidomide-Pip hydrochloride 99.18% 否
HY-131159 Thalidomide-O-C8-Boc Inducer 95.12% 否
HY-170428 IPS-06061 Degrader / 否
HY-137340 WH-10417-099 98.14% 否
HY-139540 Pomalidomide-6-OH 98.09% 否
HY-147858A PROTAC EGFR degrader 7 diTFA 99.19% 否
HY-149561 Thalidomide-5-O-C4-NH2 hydrochloride Inducer 99.98% 否
HY-151886 NU223612 Inhibitor / 否
HY-155260 Pomalidomide-5-C4-NH2 hydrochloride 98.63% 否
HY-155268 Pomalidomide-5-C12-NH2 hydrochloride 98.07% 否
HY-157767 Abd110 Inhibitor / 否
HY-158381 PROTAC PTP1B degrader 1 Degrader 99.37% 否
HY-161130 Lenalidomide 4'-PEG3-amine dihydrochloride / 否
HY-162014 WDR5 degrader-1 Degrader 98.00% 否
HY-162702 AZ'3137 Degrader 99.90% 否
HY-163938 PROTAC erf3a Degrader-1 99.44% 否
HY-172590 LZ-07 / 否
HY-174371 INNO-220 98.60% 否
HY-175764 FIP22 / 否
HY-177008 PROTAC HER2 degrader-1 98.0% 否
HY-W342590 CRBN ligand-9 98.0% 否
HY-W760183 EM12-SO2F 99.15% 否
HY-139339 Pomalidomide 4'-alkylC6-azide 99.43% 否
HY-160244 Pomalidomide 5'-piperazine-4-methylpiperidine dihydrochloride 98.08% 否
HY-W1120221 Lenalidomide-C3-NH2 / 否
HY-W244814 CRBN ligand-224 / 否
HY-W244823 CRBN ligand-661 96.71% 否
HY-W458077 Desamino lenalidomide-7-OH / 否
HY-W580117 CRBN ligand-788 / 否
HY-W586325 Desamino lenalidomide-5-COOH 99.01% 否
HY-W586822 N-Methylated pomalidomide 97.86% 否
HY-W867177 CRBN ligand-617 / 否
HY-130682 Lenalidomide-propargyl-C2-amido-Ph-NH2 hydrochloride / 否
HY-136160 Thalidomide 4'-oxyacetamide-alkyl-C2-amine hydrochloride Inducer 99.30% 否
HY-145226 XY-06-007 Inhibitor 98.9% 否
HY-161233 BTX-6654 / 否
HY-130707 K-Ras ligand-Linker Conjugate 3 / 否
HY-130823 K-Ras ligand-Linker Conjugate 5 99.79% 否
HY-133137A SJF620 hydrochloride Inhibitor 99.28% 否
HY-141481 DP-C-4 Inhibitor 98.15% 否
HY-44148 FAK ligand-Linker Conjugate 1 98.91% 否
HY-122725 Lenalidomide-C5-NH2 98.45% 否
HY-122822 GSK699 98.80% 否
HY-126534S Abemaciclib metabolite M18-d8 Inhibitor 98.47% 否
HY-131295 PD0325901-O-C2-dioxolane Inhibitor 98.62% 否
HY-131887 Pomalidomide-C6-COOH 98.02% 否
HY-132856 Lenalidomide-C5-amido-Boc 95.10% 否
HY-132857 ZXH-4-130 99.70% 否
HY-132941 CFT-2718 / 否
HY-138882A Lenalidomide-4-aminomethyl hydrochloride 90.88% 否
HY-139336 Pomalidomide-C5-azide 97.46% 否
HY-139548 Thalidomide-5-methyl Inducer 99.87% 否
HY-139997 DDC-01-163 Degrader 99.05% 否
HY-143286A PF15 TFA Degrader 99.72% 否
HY-14658S Thalidomide-d4 Inducer 98.71% 否
HY-148662 Pomalidomide-PEG5-C2-NH2 hydrochloride / 否
HY-149559 Thalidomide-5-O-C2-NH2 hydrochloride Inducer 99.55% 否
HY-149570 Thalidomide-5-O-C13-NH2 hydrochloride Inducer 99.93% 否
HY-149576 Thalidomide-4-O-C14-NH2 hydrochloride Inducer 99.85% 否
HY-156159 Thalidomide-NH-C9-NH2 hydrochloride Inducer 99.85% 否
HY-161346 EBET-1055 Degrader / 否
HY-161696 AN5777 Inducer 98.37% 否
HY-162749 G9D-4 / 否
HY-163168 aTAG 4531 Inhibitor 99.1% 否
HY-168614 MGD-4 Degrader / 否
HY-172770 KMG-1068 / 否
HY-172930 PVTX-405 / 否
HY-173266 TO-1187 Degrader / 否
HY-173614 CC-647 Modulator 99.58% 否
HY-174444 PROTAC HDAC degrader-2 Degrader / 否
HY-174455 APH02174 / 否
HY-174866 BT-O2C Inhibitor / 否
HY-177928 Adavosertib acid / 否
HY-179055 PROTAC DAPK1 Degrader-1 Degrader / 否
HY-179717 WZS0347 Degrader / 否
HY-44063 Thalidomide-NH-PEG3-NH-Boc Inducer 97.20% 否
HY-A0003S Lenalidomide-d5 Inducer 99.32% 否
HY-W245311 E3 ligase Ligand 51 Ligand / 否
HY-W457950 Thalidomide-5-propargyl Inducer 95.87% 否
HY-W733888 CRBN ligand-187 / 否
HY-130949B Thalidomide-4-O-C7-NH2 hydrochloride 99.80% 否
HY-148834B Pomalidomide-piperazine hydrochloride / 否
HY-170108 CRBN ligand-47 99.93% 否
HY-46011 (3S)Lenalidomide-5-methylpiperazine benzenesulfonate / 否
HY-49390 (S)-Glutarimide-amide-Py-piperidine-CHO / 否
HY-W079257 Desamino lenalidomide-7-F ≥98.0% 否
HY-W1130394 Thalidomide-O-amido-PEG2-Mal 97.74% 否
HY-W249075 CRBN ligand-882 / 否
HY-W441376 Thalidomide-1-Me,4-OH ≥98.0% 否
HY-W458035 Desamino lenalidomide-alkynes / 否
HY-W586316 Desamino lenalidomide-6-Br-5-F / 否
HY-W586328 Desamino lenalidomide-5-CO / 否
HY-W586333 Desamino lenalidomide-5-C-COOH / 否
HY-W586342 Desamino lenalidomide-COOH 98.58% 否
HY-W586344 Desamino lenalidomide-4-C-COOH / 否
HY-W586819 C5 Lenalidomide-CH3 / 否
HY-W586820 N-Methyl-desamino lenalidomide-NH2 / 否
HY-W589407 Desamino lenalidomide-6-propyne / 否
HY-W592698 CRBN ligand-704 / 否
HY-W674436 (S)-Thalidomide-4-OH 98.0% 否
HY-W867176 CRBN ligand-618 / 否
HY-W875713 5-Fluoro-lenalidomide / 否
HY-W883327 CRBN ligand-430 / 否
HY-W883787 Hydrouracil-4-fluorobenzoate / 否
HY-W883939 CRBN ligand-774 / 否
HY-W886311 CRBN ligand-884 / 否
HY-W886312 CRBN ligand-883 / 否
HY-W888970 3-(4-Bromo-2-fluorophenyl)piperidine-2,6-dione 98.55% 否
HY-W998252 CRBN ligand-206 / 否
HY-W998278 Desamino lenalidomide-acetylene-C2-NH2 / 否
HY-W998284 Thalidomide-O-C2-alkyne 99.67% 否
HY-W998295 E3 ligase Ligand PG-piperidine-acetaldehyde / 否
HY-122725A Lenalidomide-C5-NH2 TFA 98.94% 否
HY-129775 K-Ras ligand-Linker Conjugate 1 / 否
HY-129776 K-Ras ligand-Linker Conjugate 2 / 否
HY-130988A Ipatasertib-NH2 dihydrochloride / 否
HY-141486 (Rac)-PROTAC PARP/EGFR ligand 1 / 否
HY-145281 MS98 Inhibitor / 否
HY-176457 ZS3-046 / 否
HY-181035 DN1679 Degrader / 否
HY-122653 CCT367766 / 否
HY-130822 K-Ras ligand-Linker Conjugate 4 98.76% 否
HY-130981 FN-1501-propionic acid / 否
HY-171334A P1D-34 / 否
HY-174458 MD-4251 Degrader / 否
HY-130612 PROTAC BRD2/BRD4 degrader-1 Inhibitor / 否
HY-130963B Thalidomide-4-O-C10-NH2 hydrochloride 95.57% 否
HY-130965B Thalidomide-PEG3-NH2 hydrochloride Inducer 98.02% 否
HY-130991A K-Ras ligand-Linker Conjugate 6 formate 98.93% 否
HY-131875 Pomalidomide 4'-alkylC3-acid 98.0% 否
HY-132288 Pom-8PEG 95.09% 否
HY-132862 ZXH-4-137 Chemical / 否
HY-132944 (R)-Pomalidomide-pyrrolidine Chemical / 否
HY-138882 Lenalidomide-4-aminomethyl / 否
HY-139541 Pomalidomide-5-O-CH3 / 否
HY-139542 Pomalidomide-6-O-CH3 / 否
HY-139543 Thalidomide-5-PEG2-Cl Inducer 96.57% 否
HY-139544 Thalidomide-5-propoxyethanamine Inducer / 否
HY-139545 Thalidomide-4-C3-NH2 hydrochloride Inducer / 否
HY-139546 Thalidomide-5-propargyne-NH2 hydrochloride Inducer / 否
HY-139547 Thalidomide-5,6-Cl Inducer / 否
HY-139549 Thalidomide-benzo Inducer / 否
HY-139996 Pomalidomide-C5-Dovitinib / 否
HY-143286 PF15 Inhibitor / 否
HY-143435 AG6033 Inducer / 否
HY-145925C (S,R)-CFT8634 Inhibitor / 否
HY-148275 KTX-955 Inhibitor / 否
HY-148276 KTX-497 / 否
HY-148277 KTX-612 / 否
HY-149560 Thalidomide-5-O-C3-NH2 hydrochloride Inducer 99.08% 否
HY-149562 Thalidomide-5-O-C5-NH2 hydrochloride Inducer / 否
HY-149563 Thalidomide-5-O-C6-NH2 hydrochloride Inducer / 否
HY-149564 Thalidomide-5-O-C7-NH2 hydrochloride Inducer 98.13% 否
HY-149565 Thalidomide-5-O-C8-NH2 hydrochloride Inducer / 否
HY-149566 Thalidomide-5-O-C9-NH2 hydrochloride Inducer 99.59% 否
HY-149567 Thalidomide-5-O-C10-NH2 hydrochloride Inducer 99.37% 否
HY-149568 Thalidomide-5-O-C11-NH2 hydrochloride Inducer / 否
HY-149569 Thalidomide-5-O-C12-NH2 hydrochloride Inducer 99.90% 否
HY-149571 Thalidomide-5-O-C14-NH2 hydrochloride Inducer 97.70% 否
HY-149572 Thalidomide-4-O-C9-NH2 hydrochloride Inducer 99.26% 否
HY-149573 Thalidomide-4-O-C11-NH2 hydrochloride Inducer 99.94% 否
HY-149574 Thalidomide-4-O-C12-NH2 hydrochloride Inducer 95.57% 否
HY-149575 Thalidomide-4-O-C13-NH2 hydrochloride Inducer 99.75% 否
HY-150799 CRBN ligand-1 / 否
HY-153321A (R,R)-Bexobrutideg Degrader 98.83% 否
HY-153337 Pomalidomide-C11-NH2 / 否
HY-153337A Pomalidomide-C11-NH2 hydrochloride 96.50% 否
HY-153959 Thalidomide-O-amido-C11-COOH / 否
HY-155072 PROTAC BTK Degrader-5 Degrader / 否
HY-155255 Thalidomide-5-PEG2-NH2 hydrochloride Inducer / 否
HY-155256 Thalidomide-5-PEG6-NH2 hydrochloride Inducer 99.20% 否
HY-155257 Thalidomide-5-PEG7-NH2 hydrochloride Inducer 98.79% 否
HY-155258 Pomalidomide-PEG7-NH2 hydrochloride 97.53% 否
HY-155259 Pomalidomide-5-C3-NH2 hydrochloride 96.02% 否
HY-155261 Pomalidomide-5-C5-NH2 hydrochloride / 否
HY-155263 Pomalidomide-5-C7-NH2 hydrochloride / 否
HY-155264 Pomalidomide-5-C8-NH2 hydrochloride / 否
HY-155265 Pomalidomide-5-C9-NH2 hydrochloride 98.68% 否
HY-155266 Pomalidomide-5-C10-NH2 hydrochloride 95.00% 否
HY-155267 Pomalidomide-5-C11-NH2 hydrochloride 98.20% 否
HY-155269 Pomalidomide-5-C13-NH2 hydrochloride / 否
HY-155270 Pomalidomide-5-C14-NH2 hydrochloride / 否
HY-156160 Thalidomide-NH-C10-NH2 hydrochloride Inducer 95.58% 否
HY-156161 Thalidomide-NH-C13-NH2 hydrochloride Inducer / 否
HY-156162 Thalidomide-NH-C14-NH2 hydrochloride Inducer / 否
HY-156163 Thalidomide-5-NH-PEG1-NH2 hydrochloride Inducer / 否
HY-156164 Thalidomide-5-NH-PEG2-NH2 hydrochloride Inducer / 否
HY-156165 Thalidomide-5-NH-PEG3-NH2 hydrochloride Inducer / 否
HY-156170 Thalidomide-5-NH-PEG5-NH2 hydrochloride Inducer / 否
HY-156171 Thalidomide-5-NH-PEG6-NH2 hydrochloride Inducer / 否
HY-156172 Thalidomide-NH-PEG6-NH2 hydrochloride Inducer / 否
HY-156726 Pomalidomide-amino-PEG4-C4-Cl / 否
HY-157426 GSPT1 degrader-3 Degrader / 否
HY-157510 Thalidomide-O-C3-azide Inducer / 否
HY-157511 Thalidomide-O-C5-azide / 否
HY-157515 Thalidomide 4'-ether-PEG2-azide / 否
HY-157587 E3 ligase Ligand-Linker Conjugate 29 / 否
HY-157588 (S)-Thalidomide-Piperazine-CH2-Pyrrolidine-C2-OH Inducer / 否
HY-157594 E3 ligase Ligand-Linker Conjugate 37 / 否
HY-157595 E3 ligase Ligand-Linker Conjugate 38 / 否
HY-157599 E3 ligase Ligand-Linker Conjugate 65 / 否
HY-157600 E3 ligase Ligand-Linker Conjugate 66 / 否
HY-157635 E3 Ligase Ligand-linker Conjugate 92 / 否
HY-157636 E3 Ligase Ligand-linker Conjugate 93 / 否
HY-157637 E3 Ligase Ligand-linker Conjugate 94 / 否
HY-157747 E3 Ligase Ligand-linker Conjugate 99 / 否
HY-157748 E3 Ligase Ligand-linker Conjugate 100 / 否
HY-157756 E3 Ligase Ligand-linker Conjugate 104 / 否
HY-157757 E3 Ligase Ligand-linker Conjugate 105 / 否
HY-157758 (S)-Thalidomide-piperazine-pyrimidine-piperazine-C2-O-CH2-COO-C(CH3)3 Inducer / 否
HY-157759 (S)-Thalidomide-piperazine-pyrimidine-piperazine-C2-O-C2-OH Inducer / 否
HY-157760 (S)-Thalidomide-piperazine-pyrimidine-piperazine-C2-OH Inducer / 否
HY-157761 E3 Ligase Ligand-linker Conjugate 106 / 否
HY-158062 LC-1-40 / 否
HY-158152 PROTAC CRBN ligand-2 / 否
HY-158325 PROTAC FLT-3 degrader 4 / 否
HY-159087 RGB110 / 否
HY-160017 Pomalidomide-5'-C8-acid 99.76% 否
HY-160151 TP1L / 否
HY-161131 Lenalidomide 4'-alkyl-C3-azide / 否
HY-161183 (S)-Thalidomide-O-(1S,3r)-C4H4-N(Me)-Pip-C2-O-C-boc Inducer / 否
HY-161184 Deoxy-thalidomide-piperidine-C-piperazine-C2-OH Inducer / 否
HY-161186 Thalidomide-piperidine-C-azetidine-C2-O-C-boc Inducer / 否
HY-161187 Thalidomide-piperidine-1,6-diazaspiro[3.3]heptane-boc Inducer / 否
HY-161188 Thalidomide-O-C4H4-N(Me)-piperidine-C2-OH Inducer / 否
HY-161189 Thalidomide-2,6-diazaspiro[3.4]octane-C-piperidine-C2-O-C-boc Inducer / 否
HY-161190 Thalidomide-piperidine-C-2,6-diazaspiro[3.3]heptane-C2-OH Inducer / 否
HY-161191 Thalidomide-azetidine-piperazine-C2-O-C2-OH Inducer / 否
HY-161192 Thalidomide-O-C4H4-N(Me)-piperidine-C-boc Inducer / 否
HY-161193 Thalidomide-piperazine-(R)-C-pyrrolidine-C-boc Inducer / 否
HY-161195 Deoxy-thalidomide-piperidine-C-piperazine-C-boc Inducer / 否
HY-161196 Thalidomide-2,6-diazaspiro[3.4]octane-C-piperidine-C-boc Inducer / 否
HY-161197 Thalidomide-2,6-diazaspiro[3.4]octane-C-piperidine-C2-O-C2-OH Inducer / 否
HY-161198 Thalidomide-azetidine-pyrrolidine-C-piperidine-C-boc Inducer / 否
HY-161199 Thalidomide-azetidine-pyrrolidine-C-piperidine-C2-OH Inducer / 否
HY-161200 Thalidomide-piperazine-C-azetidine-C2-OH Inducer / 否
HY-161201 Thalidomide-piperazine-pyrimidine-piperazine-C-boc Inducer / 否
HY-161202 Thalidomide-piperidine-O-piperidine-C2-OH Inducer / 否
HY-161203 Thalidomide-azetidine-piperazine-C2-O-C-boc Inducer / 否
HY-161204 Thalidomide-O-C4H4-N(Me)-piperidine-boc Inducer / 否
HY-161205 Thalidomide-PIP-(R)C-pyrrolidine-boc Inducer / 否
HY-161206 Thalidomide-Pip-C-Pip-O-C-boc Inducer / 否
HY-161208 Deoxy-thalidomide-Pip-C-PIP-boc Inducer / 否
HY-161209 Thalidomide-2,6-diazaspiro[3.4]octane-C-Pip-boc Inducer / 否
HY-161210 Thalidomide-azetidine-C-PIP-C-boc Inducer / 否
HY-161250 Pomalidomide-NH-PEG6-amide-C2-CPI-1612 / 否
HY-161632 PROTAC EGFR degrader 10 Degrader / 否
HY-161654 PROTAC SOS1 degrader-10 / 否
HY-161668 Ru-Poma / 否
HY-162098 PROTAC tubulin-Degrader-1 / 否
HY-162180 E3 Ligase Ligand-linker Conjugate 2 / 否
HY-162181 E3 Ligase Ligand-linker Conjugate 5 / 否
HY-162182 E3 Ligase Ligand-linker Conjugate 7 / 否
HY-162183 E3 Ligase Ligand-linker Conjugate 9 / 否
HY-162184 E3 ligase Ligand-Linker Conjugate 11 / 否
HY-162185 E3 Ligase Ligand-linker Conjugate 12 / 否
HY-162186 E3 Ligase Ligand-linker Conjugate 13 / 否
HY-162187 E3 Ligase Ligand-linker Conjugate 14 / 否
HY-162189 E3 Ligase Ligand-linker Conjugate 16 / 否
HY-162190 E3 Ligase Ligand-linker Conjugate 17 / 否
HY-162191 E3 Ligase Ligand-linker Conjugate 18 / 否
HY-162192 E3 Ligase Ligand-linker Conjugate 20 / 否
HY-162194 E3 Ligase Ligand-linker Conjugate 28 / 否
HY-162195 E3 ligase Ligand-Linker Conjugate 34 / 否
HY-162196 E3 ligase Ligand-Linker Conjugate 39 / 否
HY-162197 E3 ligase Ligand-Linker Conjugate 41 / 否
HY-162198 E3 ligase Ligand-Linker Conjugate 43 / 否
HY-162199 E3 Ligase Ligand-linker Conjugate 45 / 否
HY-162200 E3 Ligase Ligand-linker Conjugate 47 / 否
HY-162203 E3 Ligase Ligand-linker Conjugate 51 / 否
HY-162204 E3 Ligase Ligand-linker Conjugate 54 / 否
HY-162205 E3 Ligase Ligand-linker Conjugate 55 / 否
HY-162206 E3 Ligase Ligand-linker Conjugate 58 / 否
HY-162538 LC-MI-3 / 否
HY-163210 Pomalidomide 5'-fluoro-6'-piperazine-4-methylpiperidine hydrochloride / 否
HY-163221 (S)-Thalidomide-piperazine-(1S,4r)-cyclohexane-N(Me)-Boc Inducer / 否
HY-163225 (S)-Thalidomide-piperazine-(1S,4r)-cyclohexane-NH-Boc Inducer / 否
HY-163226 (1R,5S)-Thalidomide-3,8-diazabicyclo[3.2.1]octane-(1R,4r)-cyclohexane-NH-Boc Inducer / 否
HY-163227 (1R,4R)-Thalidomide-2,5-diazabicyclo[2.2.1]heptane-(1R,4r)-cyclohexane-NH-Boc Inducer / 否
HY-163229 (1r,4r)-Thalidomide-piperidine-N(Me)-CH-cyclohexane-NH-Boc Inducer / 否
HY-163230 (1R,5S)-Thalidomide-3,8-diazabicyclo[3.2.1]octane-Boc Inducer / 否
HY-163232 Phthalimidinoglutarimide-piperidine-NH-Boc / 否
HY-163233 Lenalidomide 5'-piperazine / 否
HY-163234 Phthalimidinoglutarimide-piperidine-NH2 / 否
HY-163236 Thalidomide-piperidine-O-azetidine-acetic acid Inducer / 否
HY-163237 Thalidomide-piperidine-O-azetidineethanol Inducer / 否
HY-163238 Thalidomide-azetidine-CH-piperazineethanol Inducer / 否
HY-163239 (R)-Thalidomide-piperazine-pyrrolidineethanol Inducer / 否
HY-163851 PROTAC Vif degrader-1 Inhibitor / 否
HY-163922 CRBN ligand-1-piperidine-Me / 否
HY-164906 TMX-2138 Degrader / 否
HY-168274 PROTAC TRIB2 degrader-1 Inducer / 否
HY-168867 RD-23 / 否
HY-168869 Tamoxifen-PEG-Clozapine Degrader / 否
HY-168910 PROTAC c-Met degrader-3 Degrader / 否
HY-168964 Ethanolamine-Thalidomide-4-OH / 否
HY-169077 IKZF3 degrader 1 Degrader / 否
HY-169082 JQ-1 (carboxylic acid)-NH-C2-NH-COOH / 否
HY-169232 PCC16 chloride Degrader / 否
HY-169235 DHHC3 ligand 1 / 否
HY-169362 Lenalidomide-Pip-butyn / 否
HY-169401 L321-NH-C3-PEG3-C1-NH2 / 否
HY-169954 CRBN ligand-10 / 否
HY-170058 CRBN ligand-12 / 否
HY-170082S 2,4-Di-tert-butoxypyrimidine-2-13C-1,3-15N2 / 否
HY-170126S 9-Amino-1,2,3,4-tetrahydroacridin-1-ol-d3 Maleate / 否
HY-170207S Aurothioglucose 70%-13C6 / 否
HY-170335 PROTAC c-Met degrader-2 Degrader / 否
HY-170390 AB3067 Degrader / 否
HY-170413 PROTAC BTK Degrader-12 Degrader / 否
HY-170449 E3 ligase Ligand 48 / 否
HY-170601 PROTAC JNK1-targeted-1 Degrader / 否
HY-170673 E3 Ligase Ligand-linker Conjugate 156 / 否
HY-170820 XYD049 / 否
HY-170869 PROTAC FGFR1 degrader-1 Degrader / 否
HY-170982 MS910 Inhibitor / 否
HY-170996 ROR1 ligand-1 Degrader / 否
HY-171893 CRBN ligand-185 Ligand / 否
HY-172368 PROTAC CARM1/IKZF3 degrader-1 / 否
HY-172593 E3 Ligase Ligand-linker Conjugate 182 / 否
HY-172949 E3 Ligase Ligand-linker Conjugate 187 / 否
HY-172954 Androgen receptor ligand 1 / 否
HY-173359 TYK2 ligand 2 Ligand / 否
HY-173437 CW-2 Degrader / 否
HY-173631 (S)-dHTC1 Degrader / 否
HY-174087 Thalidomide-4-OH-C11-OH / 否
HY-174135 PROTAC HPK1 Degrader-4 Degrader / 否
HY-174235 Thalidomide-OCH2-amide-PEG2-C2-Boc / 否
HY-174247 CPS-021 Degrader / 否
HY-174266 WB156 Degrader / 否
HY-174315 WZH-17-002 / 否
HY-174329 MRT-5702D / 否
HY-174401 PROTAC HDAC6 degrader 5 Inhibitor / 否
HY-174405 PROTAC PDE4 degrader-1 / 否
HY-174410 PDE4 ligand 2 / 否
HY-174443 PROTAC sEH degrader-2 Degrader / 否
HY-174461 PROTAC PI3Kα degrader-1 Degrader / 否
HY-174471 HDAC-IN-90 Ligand / 否
HY-174473 Thalidomide-NH-alkynes / 否
HY-174796 E3 Ligase Ligand-linker Conjugate 195 / 否
HY-174797 Dione-piperidine-indazol-piperazin-cyclohexyl-NH2 / 否
HY-174811 PROTAC BRD4 Degrader-33 Degrader / 否
HY-174813 Pomalidomide-PEG3-Cys / 否
HY-174862 dASK1 Degrader / 否
HY-174863 Pomalidomide-C2-PEG-NHCO-C2-COOH / 否
HY-174869 Pomalidomide-5-C7-NH2 / 否
HY-174870 PROTAC ERα Degrader-11 / 否
HY-174877 PROTAC HDAC6 degrader 6 Degrader / 否
HY-174879 Dioxopiperidin-phthalimidine-PEG3-NBoc / 否
HY-174880 CRBN ligand-8-O-C6-NH2 / 否
HY-175271 JWJ-01-378 / 否
HY-175273 MA191 / 否
HY-175281 SJ11646 / 否
HY-175320 PROTAC c-Met degrader-5 / 否
HY-175334 DHC-286 / 否
HY-175392 PROTAC sEH-degrader-3 Degrader / 否
HY-175397 Dth Degrader / 否
HY-175453 MRT-23227 / 否
HY-175459 PROTAC FAK degrader 3 Degrader / 否
HY-175541 TQ-3959 Degrader / 否
HY-175545 CRBN ligand-Linker Conjugate 1 / 否
HY-175600 MI-2-80 Degrader / 否
HY-175601 DD-04-038 Degrader / 否
HY-175602 TM-04-064-02 Degrader / 否
HY-175610 PROTAC FLT3/JAK2/BRD4 Degrader-1 Degrader / 否
HY-175766 CRBN Ligand-Linker Conjugate 2 / 否
HY-175830 PROTAC AURKA degrader 1 Degrader / 否
HY-175875 HRZ-01-082-5 Degrader / 否
HY-176125 E3 Ligase Ligand-linker Conjugate 184 / 否
HY-176128 BWA-6047 Degrader / 否
HY-176166 PD-M6 Degrader / 否
HY-176180 PROTAC STING degrader-4 / 否
HY-176181 Thalidomide-4-PEG4-OTs Chemical / 否
HY-176225 BY13 / 否
HY-176227 Thalidomide-piperidine-azetidine-Br Chemical / 否
HY-176425 E3 Ligase Ligand-linker Conjugate 186 / 否
HY-176430 Lenalidomide-amide-pimelic acid / 否
HY-176449 PROTAC BRD4 Degrader-32 Inhibitor / 否
HY-176470 Thalidomide-N-C-piperidine-C7-Br / 否
HY-176740 PROTAC Bcl-xL degrader-4 / 否
HY-177694 PROTAC AR Degrader-11 Degrader / 否
HY-177724 GSPT1 degrader-11 Degrader / 否
HY-177725 MG degrader 2 Degrader / 否
HY-177728 MG degrader 3 / 否
HY-177730 PROTAC BRD4 Degrader-40 Degrader / 否
HY-177751 GSPT1 degrader-12 / 否
HY-177752 GSPT1 degrader-13 / 否
HY-177753 GSPT1 degrader-14 / 否
HY-177758 PROTAC HDAC6 degrader 8 Degrader / 否
HY-178034 PROTAC OSBP Degrader-1 Degrader / 否
HY-178066 PROTAC BCL-xL/BCL-w Degrader 1 Degrader / 否
HY-178118 PROTAC PDIA1 degrader 1 Degrader / 否
HY-178176 PROTAC CB1R Degrader-1 / 否
HY-178242 PROTAC EGFR degrader 16 Degrader / 否
HY-178360 NP1192 / 否
HY-178452 PROTAC CDK4/6/9 degrader 1 / 否
HY-178459 PROTAC HPK1 Degrader-6 Degrader / 否
HY-178483 E3 Ligase Ligand-linker Conjugate 211 / 否
HY-178497 ZJK-807 / 否
HY-178510 JQ1-S(GlcNAc)Cq Degrader / 否
HY-178516 PROTAC CDK4/6/9 degrader 2 Degrader / 否
HY-178518 Thalidomide-C1-O-CO-C2-Piperazine-CO-C1-Azacyclohexane-C1-Piperazine / 否
HY-178777 BCL6-760 Degrader / 否
HY-178858 PROTAC FLT3/CHK1 Degrader-1 / 否
HY-178964 PROTAC RET Degrader 1 Degrader / 否
HY-179060 LAG-3 PROTAC-1 Degrader / 否
HY-179075 PROTAC BCL6/IKZF1/3 Degrader-1 Degrader / 否
HY-179077 PROTAC BTK/IKZF1/3 Degrader-1 Degrader / 否
HY-179096 E3 Ligase Ligand-linker Conjugate 213 / 否
HY-179112 PROTAC IKKβ/NR4A1 degrader-1 / 否
HY-179157 MA203 / 否
HY-179166 PROTAC sEH-degrader-4 Degrader / 否
HY-179307 E3 ligase Ligand 77 / 否
HY-179467 PROTAC hCAII degrader-1 Degrader / 否
HY-179499 PROTAC EZH2 Degrader-9 / 否
HY-179642 E3 Ligase Ligand-linker Conjugate 223 / 否
HY-179644 E3 Ligase Ligand-linker Conjugate 222 / 否
HY-179657 PROTAC MLT Degrader 1 / 否
HY-179688 PROTAC CDK2/4 Degrader-1 Degrader / 否
HY-179715 PROTAC JAK1/2 degrader-1 / 否
HY-179727 PROTAC HPK1 Degrader-7 Activator / 否
HY-179730 CRBN ligand-190 / 否
HY-179732 PROTAC ALK degrader-4 / 否
HY-179733 CRBN ligand-191 / 否
HY-179735 CRBN ligand-192 / 否
HY-180179 BLIMP-1 ligand-Linker Conjugate 1 / 否
HY-180485 PROTAC D16-M1P2 Degrader / 否
HY-180538 MRT-31619 Degrader / 否
HY-180550 ZW-18-116 Degrader / 否
HY-180555 SN38-(PEG)2-Pom-α Activator / 否
HY-180836 DIX-01 / 否
HY-180928 LCK degrader-3 Degrader / 否
HY-180956 PROTAC ALK degrader-5 / 否
HY-180973 CRBN ligand-893 / 否
HY-180977 P19P Degrader / 否
HY-180979 P22D Degrader / 否
HY-180981 P19As Degrader / 否
HY-180993 CRBN ligand-894 / 否
HY-181023 PROTAC HDAC8 Degrader-3 Degrader / 否
HY-181024 PROTAC HDAC8 Degrader-4 Degrader / 否
HY-181042 CRBN ligand-895 / 否
HY-181043 CRBN ligand-895-PEG2-N3 / 否
HY-181143 PROTAC Tubulin degrader-2 / 否
HY-181147 PROTAC HSP70 Degrader-1 Degrader / 否
HY-181311 CCT400028 / 否
HY-185009 GSK702 / 否
HY-42771 Thalidomide-4-O-CH2-COO(t-Bu) Inducer 99.26% 否
HY-A0003S2 Lenalidomide-13C5,15N Inducer / 否
HY-N12876 (18α)-Oleanolic acid / 否
HY-RS03143 CRBN Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-W077589A Lenalidomide-5-aminomethyl / 否
HY-W1128213 IKZF2-degrader 2 Degrader / 否
HY-W584513 Thalidomide-NH-(CH2)2-NH-Boc Inducer / 否
HY-W584514 Thalidomide-NH-(CH2)2-NH2 TFA Inducer 99.38% 否
HY-W584515 Thalidomide-NH-(CH2)3-NH-Boc Inducer / 否
HY-W584516 Thalidomide-5-NH-CH2-COO(t-Bu) Inducer / 否
HY-W584517 Thalidomide-5-O-CH2-COO(t-Bu) Inducer / 否
HY-W584520 Thalidomide-4-NH-PEG1-NH-Boc Inducer / 否
HY-W584521 Thalidomide-4-NH-PEG1-NH2 TFA Inducer / 否
HY-W584522 Thalidomide-4-NH-PEG1-COO(t-Bu) Inducer / 否
HY-W584523 Thalidomide-4-NH-PEG1-COOH TFA / 否
HY-W584524 Thalidomide-4-NH-PEG2-COO(t-Bu) Inducer / 否
HY-W597583 2-(2,6-Dioxopiperidin-3-yl)phthalimidine NMe / 否
HY-W877239 Pomalidomide 7'OMe / 否
HY-W940885 Pomalidomide-NH-C13-OH / 否
HY-W957152 Deoxy-thalidomide-C4-NH2 / 否
HY-122749 Dimethyl 3-hydroxyphthalate-amido-C4-N3 / 否
HY-131717A Thalidomide-NH-CH2-COOH TFA Inducer / 否
HY-139332 Pomalidomide 4'-PEG6-azide / 否
HY-139333 Pomalidomide 4'-PEG5-azide / 否
HY-139341 Pomalidomide 4'-alkylC3-azide / 否
HY-139343 Pomalidomide 4'-alkylC2-azide / 否
HY-157514 Thalidomide 4'-ether-PEG1-azide Inducer / 否
HY-159164 PROTAC CRBN ligand-3 / 否
HY-160531 IKZF1-degrader-1 Degrader / 否
HY-161134 Lenalidomide 4'-PEG2-azide / 否
HY-161538 Lenalidomide-C6-Br / 否
HY-161675 Lenalidomide-5-bromopentanamide / 否
HY-164391 Pomalidomide-C2-amide-C4-Br / 否
HY-169861 PROTAC SMARCA2/4 degrader-37 Degrader / 否
HY-170074 CRBN ligand-14 / 否
HY-170075 CRBN ligand-16 / 否
HY-170076 CRBN ligand-17 / 否
HY-170095 CRBN ligand-63 / 否
HY-170126 CRBN ligand-74 / 否
HY-170127 CRBN ligand-76 / 否
HY-170131 CRBN ligand-84 / 否
HY-170213 CRBN ligand-183 / 否
HY-170350 Pomalidomide-PEG2-OMs / 否
HY-171224 CRBN ligand-45 / 否
HY-171775 CRBN ligand-184 / 否
HY-174249 CRBN ligand-186 / 否
HY-177777 FL2-14 / 否
HY-178695 E3 Ligase Ligand-linker Conjugate 216 / 否
HY-181154 PROTAC SARS-CoV-2 Mpro degrader-5 Degrader / 否
HY-181193 PROTAC SARS-CoV-2 Mpro degrader-7 Degrader / 否
HY-401504 Thalidomide-azetidine-COOH / 否
HY-403544 CbzNH-(C5-O)2-C4-Boc / 否
HY-48024 CRBN ligand-885 98.10% 否
HY-48214 CRBN ligand-222 / 否
HY-48364 Hydrouracil-(4-Br-2,6-difluorobenzene) / 否
HY-A0003S3 Lenalidomide-d4 Inducer / 否
HY-RS16541 Crbn Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS22973 Crbn Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-W074850 Desamino lenalidomide-ethynyl / 否
HY-W090651 Thalidomide-4-OH-(S)-CH3 / 否
HY-W1000893 Desamino lenalidomide-2,6-diazaspiro[3.3]heptane / 否
HY-W1001974 CRBN ligand-657 / 否
HY-W1003687 CRBN ligand-749 / 否
HY-W1003884 Lenalidomide 5'-piperazine-C1-piperidine / 否
HY-W1005243A CRBN ligand-869 / 否
HY-W1008600 CRBN ligand-531 / 否
HY-W1008601 CRBN ligand-614 / 否
HY-W1008602 CRBN ligand-613 / 否
HY-W1008603 CRBN ligand-659 / 否
HY-W1008737 CRBN ligand-234 / 否
HY-W1008850 CRBN ligand-198 / 否
HY-W1008851 CRBN ligand-236 / 否
HY-W1008852 CRBN ligand-237 / 否
HY-W1008853 CRBN ligand-228 / 否
HY-W1008855 CRBN ligand-229 / 否
HY-W1008859 CRBN ligand-393 / 否
HY-W1008860 CRBN ligand-656 / 否
HY-W1008861 CRBN ligand-615 / 否
HY-W1008862 CRBN ligand-208 / 否
HY-W1008863 CRBN ligand-410 / 否
HY-W1008864 CRBN ligand-231 / 否
HY-W1008865 CRBN ligand-616 / 否
HY-W1008866 CRBN ligand-230 / 否
HY-W1008867 CRBN ligand-286 / 否
HY-W1008868 CRBN ligand-411 / 否
HY-W1008869 CRBN ligand-684 / 否
HY-W1008870 CRBN ligand-235 / 否
HY-W1008871 CRBN ligand-202 / 否
HY-W1008876 CRBN ligand-686 / 否
HY-W1008877 CRBN ligand-193 / 否
HY-W1008878 CRBN ligand-683 / 否
HY-W1008879 CRBN ligand-685 / 否
HY-W1009349 CRBN ligand-870 / 否
HY-W1111714 3-(5-Bromo-2-chlorophenyl)piperidine-2,6-dione / 否
HY-W1112836 2-(2,6-Dioxopiperidin-3-yl)phthalimidine-O-piperidine / 否
HY-W1114859 Desamino lenalidomide-Pip-CO-piperazine hydrochloride / 否
HY-W1114860 2-(2,6-Dioxopiperidin-3-yl)phthalimidine-alkyne-piperidine / 否
HY-W1114861 Desamino lenalidomide-alkyne-C-piperazin / 否
HY-W1114863 Desamino lenalidomide-acetylene-C-piperazine hydrochloride / 否
HY-W1114864 (S)-Deoxy-thalidomide-Pip-3-hydroxypropanoic acid / 否
HY-W1114864A (S)-Deoxy-thalidomide-Pip-3-hydroxypropanoic acid hydrochloride / 否
HY-W1115204 Lenalidomide 5'-piperazine-C1-piperidine hydrochloride / 否
HY-W1115214 3-(1-Oxo-5-(3,9-diazaspiro[5.5]undecan-3-yl)isoindolin-2-yl)piperidine-2,6-dione / 否
HY-W1115214A Desamino lenalidomide-Pip-Pip hydrochloride / 否
HY-W1115215 2-(2,6-Dioxopiperidin-3-yl)phthalimidine-Piperazine-piperidine / 否
HY-W1115215A 2-(2,6-Dioxopiperidin-3-yl)phthalimidine-Piperazine-piperidine hydrochloride / 否
HY-W1115215B 2-(2,6-Dioxopiperidin-3-yl)phthalimidine-Piperazine-piperidine dihydrochloride / 否
HY-W1115217 Desamino lenalidomide-Pip-azetidine / 否
HY-W1115217A Desamino lenalidomide-Pip-azetidine hydrochloride / 否
HY-W1115219 2-(2,6-Dioxopiperidin-3-yl)phthalimidine-piperazine-C-piperidine hydrochloride / 否
HY-W1115220 2-(2,6-Dioxopiperidin-3-yl)phthalimidine-azetidine / 否
HY-W1115221 Desamino lenalidomide-azetidine-CHO / 否
HY-W1115222 (S)-Deoxy-thalidomide-(R)-pyrrolidine-3-carbaldehyde / 否
HY-W1115223 Desamino lenalidomide-C-piperazine / 否
HY-W1115224 Desamino lenalidomide-piperidine-CO / 否
HY-W1115225 Desamino lenalidomide-piperidine-C-OH / 否
HY-W1115226 Desamino lenalidomide-piperidine-C-piperazine hydrochloride / 否
HY-W1115227 Desamino lenalidomide-Pip-C-piperazine trihydrochloride / 否
HY-W1115228 Desamino lenalidomide-piperidin-piperazine / 否
HY-W1115229 Desamino lenalidomide-piperidine-O-7-azaspiro[3.5]nonane / 否
HY-W1115239 Desamino lenalidomide-piperidine-F-C-piperazine / 否
HY-W1115542 2-(2,6-Dioxopiperidin-3-yl)phthalimidine-1-(piperidin-4-ylmethyl)piperidine / 否
HY-W1120675 CRBN ligand-232 / 否
HY-W1122143A CRBN ligand-733 / 否
HY-W1128972 CRBN ligand-196 / 否
HY-W1128973 CRBN ligand-203 / 否
HY-W1130334 Thalidomide-O-PNB ester / 否
HY-W1130363 Thalidomide-O-amido-PEG1-azide / 否
HY-W1130364 Thalidomide-O-amido-PEG3-azide / 否
HY-W1130365 Thalidomide-Piperazine-PEG2-NH2 hydrochloride / 否
HY-W1130371 Bis-PEG2-amine-Thalidomide(hydrochloride) / 否
HY-W1130375 CRBN ligand-858 / 否
HY-W171304 Hydrouracil-4-Iodophenyl / 否
HY-W190931 Thalidomide-O-PEG5-alkyne / 否
HY-W243400 CRBN ligand-705 ≥96.0% 否
HY-W244820 Desamino lenalidomide-5-acetonitrile 99.56% 否
HY-W244832 CRBN ligand-619 / 否
HY-W442908 Desamino lenalidomide-6-I / 否
HY-W452755 (R)-Desamino lenalidomide-5-Br 99.69% 否
HY-W455176 CRBN ligand-408 / 否
HY-W457158 (S)-Thalidomide-5-OH / 否
HY-W457977 Desamino lenalidomide-4-acetonitrile 95.98% 否
HY-W460228 Desamino lenalidomide-4-F-7-Br 99.90% 否
HY-W539438 CRBN ligand-890 96.74% 否
HY-W580776 Desamino lenalidomide-cyano 99.91% 否
HY-W584710 Desamino lenalidomide-C2-COOH 98.29% 否
HY-W586315 Desamino lenalidomide-4-Br-5-F / 否
HY-W586326 Desamino lenalidomide-4-COOH / 否
HY-W586327 Thalidomide-5-methanol / 否
HY-W586332 Desamino lenalidomide-6-C-COOH / 否
HY-W586343 Desamino lenalidomide-7-CO / 否
HY-W587139 Hydrouracil-3-PhOH / 否
HY-W589406 Desamino lenalidomide-7-propyne / 否
HY-W592697 Dihydrouracil-Ph-piperazine-Boc / 否
HY-W593980 CRBN ligand-209 / 否
HY-W613598 tert-Butyl (S)-5-amino-4-(4-hydroxy-1-oxoisoindolin-2-yl)-5-oxopentanoate / 否
HY-W733197 Hydrouracil-(4-Chlorophenoxy)-O-C-COOH / 否
HY-W797335 CRBN ligand-200 / 否
HY-W868011 Desamino lenalidomide-4-Br-6-acetonitrile / 否
HY-W871182 Desamino lenalidomide-5-F-4-CH2NH2 hydrochloride / 否
HY-W873806 CRBN ligand-789 / 否
HY-W874585 2-(2,6-Dioxopiperidin-3-yl)phthalimidine-piperidine / 否
HY-W875721 5-Fluoro-pomalidomide / 否
HY-W877999 E3 ligase Ligand 63-N-CH2-Ph-O-CH3 / 否
HY-W878657 CRBN ligand-194 / 否
HY-W879795 NH2-MeO-Ph-amide-(2,6-Dioxo-3-Pip) / 否
HY-W881241 Thalidomide-piperidin-4-ylmethanol 99.17% 否
HY-W883329 CRBN ligand-761 / 否
HY-W883357 CRBN ligand-204 / 否
HY-W883932 Desamino lenalidomide[3,4-g]piperidine / 否
HY-W886321 CRBN ligand-392 / 否
HY-W888368 CRBN ligand-300 / 否
HY-W888967 CRBN ligand-658 / 否
HY-W891892 CRBN ligand-211 / 否
HY-W893040 CRBN ligand-871 / 否
HY-W893194 CRBN ligand-110 / 否
HY-W894177 CRBN ligand-874 / 否
HY-W898983 CRBN ligand-181 / 否
HY-W898985 CRBN ligand-148 / 否
HY-W898987 CRBN ligand-83 / 否
HY-W898991 CRBN ligand-112 / 否
HY-W898997 CRBN ligand-111 / 否
HY-W898998 CRBN ligand-164 / 否
HY-W899000 CRBN ligand-162 / 否
HY-W899002 CRBN ligand-108 / 否
HY-W936871 Hydrouracil-(4-CP) / 否
HY-W942093 Thalidomide-O-CONH-alkyne / 否
HY-W947258 CRBN ligand-207 / 否
HY-W947268 CRBN ligand-546 / 否
HY-W947269 CRBN ligand-205 / 否
HY-W947270 CRBN ligand-199 / 否
HY-W947271 CRBN ligand-201 / 否
HY-W949165 C5 Lenalidomide-6-fluoro / 否
HY-W952983 CRBN ligand-516 / 否
HY-W953097 CRBN ligand-369 / 否
HY-W953195 CRBN ligand-434 / 否
HY-W953369 CRBN ligand-542 / 否
HY-W953409 CRBN ligand-501 / 否
HY-W953411 CRBN ligand-259 / 否
HY-W953446 CRBN ligand-346 / 否
HY-W953452 CRBN ligand-630 / 否
HY-W953488 CRBN ligand-738 / 否
HY-W953509 CRBN ligand-739 / 否
HY-W953512 CRBN ligand-690 / 否
HY-W953545 CRBN ligand-446 / 否
HY-W953553 CRBN ligand-485 / 否
HY-W953559 CRBN ligand-305 / 否
HY-W953596 CRBN ligand-718 / 否
HY-W953606 CRBN ligand-562 / 否
HY-W953618 CRBN ligand-628 / 否
HY-W953619 CRBN ligand-720 / 否
HY-W953620 CRBN ligand-418 / 否
HY-W953621 CRBN ligand-345 / 否
HY-W953640 CRBN ligand-662 / 否
HY-W953648 CRBN ligand-756 / 否
HY-W953649 CRBN ligand-757 / 否
HY-W953650 CRBN ligand-711 / 否
HY-W953660 CRBN ligand-480 / 否
HY-W953669 CRBN ligand-341 / 否
HY-W953702 CRBN ligand-481 / 否
HY-W953703 CRBN ligand-482 / 否
HY-W953705 CRBN ligand-254 / 否
HY-W953708 CRBN ligand-431 / 否
HY-W953712 CRBN ligand-535 / 否
HY-W953742 CRBN ligand-302 / 否
HY-W953775 CRBN ligand-414 / 否
HY-W998236 (S)-Thalidomide-5-fluoro-6-piperazin besylate / 否
HY-W998237 (S)-Thalidomide-piperazin besylate / 否
HY-W998239 Thalidomide 5-fluoride 6-piperidine-C-OH / 否
HY-W998240 Thalidomide-azetidine-C-OH 98.53% 否
HY-W998241 Thalidomide-6-F-5-azetidine-COOH / 否
HY-W998242 Thalidomide-6-F-5-Pip-COOH / 否
HY-W998250 Thalidomide-5-F-6-I / 否
HY-W998251 Desamino lenalidomide-piperazine besylate / 否
HY-W998256 DGY-02-126-O-C-COOH / 否
HY-W998257 Thalidomide-piperidine-C-COOH / 否
HY-W998258 Thalidomide-piperidine-NH-Me / 否
HY-W998259 Thalidomide-piperazine-C-COOH / 否
HY-W998260 Pomalidomide-cyclohexane-C-COOH / 否
HY-W998261 Thalidomide-azacyclohexane / 否
HY-W998263 Thalidomide-Pip-4-one / 否
HY-W998264 4-Br-7-O-Desamino lenalidomide / 否
HY-W998265 7-F-4-I-Desamino lenalidomide / 否
HY-W998266 Desamino lenalidomide-4-Br-7-OH / 否
HY-W998267 Desamino lenalidomide-Bpin / 否
HY-W998268 3-Azathalidomide-piperazine / 否
HY-W998269 6-(2,6-Dioxopiperidin-3-yl)-2-(piperazin-1-yl)-5H-pyrrolo[3,4-d]pyrimidine-5,7(6H)-dione hydrochloride / 否
HY-W998271 E3 Ligase Ligand-linker Conjugate 221 / 否
HY-W998272 Desamino lenalidomide-piperazine hydrochloride / 否
HY-W998273 Thalidomide-S-COOH / 否
HY-W998277 Desamino lenalidomide-acetylene-C2-OH / 否
HY-W998279 Desamino lenalidomide-pent-4-yn-1-ol / 否
HY-W998280 Thalidomide-propargyl-MeOH / 否
HY-W998282 Thalidomide-propargyl-NHCH3 / 否
HY-W998283 Desamino lenalidomide-acetylene-piperidine / 否
HY-W998285 Pomalidomide-C3-alkyne / 否
HY-W998290 3-(2,6-Difluoro-4-(4-(2-hydroxyethyl)piperidin-1-yl)phenyl)piperidine-2,6-dione / 否
HY-W998294 E3 ligase Ligand PG-piperidine-C2-OH / 否
HY-W998299 Thalidomide-Pip-CH2-piperazine / 否
HY-W998300 Thalidomide-piperidin-C-piperidin / 否
HY-W998301 Thalidomide-piperidin-C-piperidin hydrochloride / 否
HY-W998302 Thalidomide-piperidin-O-piperidin / 否
HY-W998303 Thalidomide-piperidin-O-piperidin TFA / 否
HY-W998304 Thalidomide-(1-(3-azetidinylmethyl)piperazine) / 否
HY-W998305 Thalidomide-(1-(3-pyrrolidinylmethyl)piperazine) / 否
HY-W998307 Thalidomide-5-piperazine-azetidine / 否
HY-W998308 (S)-Thalidomide-azetidine-O-Pip / 否
HY-W998312 Thalidomide-O-amido-C3-COOH TFA / 否
HY-W998316 Thalidomide-piperazine-pyrrolidine dihydrochloride / 否
HY-W998318 Thalidomide-piperazine-C-azetidine TFA / 否
HY-W998319 Thalidomide-piperidine-O-piperidine dihydrochloride / 否
HY-W998320 Thalidomide-piperazine-C-pyrrolidine dihydrochloride / 否
HY-W998321 Thalidomide-piperazine-Pip dihydrochloride / 否
HY-W998322 Thalidomide-5-piperazine-azetidine TFA / 否
HY-W998327 Thalidomide-azetidine-C-piperazine TFA / 否
HY-W998328 Thalidomide-O-amido-C3-NH2 hydrochloride / 否
HY-W998330 Thalidomide-((3R)-3-pyrrolidinemethanol) / 否
HY-W998331 CC-17369 hydrochloride / 否
HY-W998335 (S)-Deoxy-thalidomide-6-F-5-piperazine benzenesulfonate / 否
HY-W998340 Thalidomide-piperazine-tert-butyl formate / 否
HY-W998343 (S)-Desamino lenalidomide-2,7-diazaspiro[3.5]nonane / 否
HY-W998346 Thalidomide-5-NH2-6-F / 否
HY-W998347 ABS-752 hydrochloride / 否
HY-W999479 tert-Butyl (trans-4-((4-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)piperazin-1-yl)methyl)cyclohexyl)carbamate / 否
HY-W999483 Thalidomide-3,8-diazabicyclo[3.2.1]octane-Boc / 否
HY-W999497 Thalidomide-azetidine-CH2-piperazine-C-COOH / 否
HY-W999527 Thalidomide-(1-(3R-pyrrolidinylmethyl)piperazine)-Boc / 否
HY-W999529 KRAS G12C degrader-2 / 否
HY-W999560 CRBN ligand-889 / 否
HY-W999565 CRBN ligand-221 / 否
HY-W999566 CRBN ligand-402 / 否
HY-W999576 CRBN ligand-220 / 否
HY-W999577 CRBN ligand-215 / 否
HY-W999578 CRBN ligand-217 / 否
HY-W999579 CRBN ligand-216 / 否
HY-W999580 CRBN ligand-399 / 否
HY-W999583 CRBN ligand-400 / 否
HY-W999585 CRBN ligand-212 / 否
HY-W999587 CRBN ligand-467 / 否
HY-W999606 CRBN ligand-674 / 否
HY-W999607 CRBN ligand-779 / 否
HY-W999618 CRBN ligand-803 / 否
HY-W999628 CRBN ligand-650 / 否
HY-W999632 CRBN ligand-238 / 否
HY-W999637 CRBN ligand-242 / 否
HY-W999646 CRBN ligand-329 / 否
HY-W999649 CRBN ligand-473 / 否
HY-W999650 CRBN ligand-675 / 否
HY-W999653 CRBN ligand-786 / 否
HY-W999654 CRBN ligand-795 / 否
HY-W999659 CRBN ligand-799 / 否
HY-W999662 CRBN ligand-836 / 否
HY-W999666 CRBN ligand-808 / 否
HY-W999667 CRBN ligand-868 / 否
HY-W999668 CRBN ligand-865 / 否
HY-W999669 Hydrouracil-4-benzazimide-7-NH2 / 否
HY-W999671 CRBN ligand-826 / 否
HY-W999673 CRBN ligand-856 / 否
HY-W999680 CRBN ligand-821 / 否
HY-W999690 CRBN ligand-839 / 否
HY-W999696 CRBN ligand-713 / 否
HY-W999697 CRBN ligand-771 / 否
HY-W999702 CRBN ligand-861 / 否
HY-W999712 CRBN ligand-811 / 否
HY-W999716 CRBN ligand-813 / 否
HY-W999717 CRBN ligand-282 / 否
HY-W999719 CRBN ligand-814 / 否
HY-W999722 CRBN ligand-846 / 否
HY-W999727 CRBN ligand-848 / 否
HY-W999740 CRBN ligand-227 / 否
HY-W999741 Thalidomide-O-C4-N3 / 否

直系同源

种属 基因名 来源 基因 ID
Macaca mulatta CRBN VGNC VGNC:71607
Felis catus CRBN VGNC VGNC:61162
Rattus norvegicus CRBN RGD RGD:1310533
Canis familiaris CRBN VGNC VGNC:108241
Bos taurus CRBN VGNC VGNC:27690
Mus musculus CRBN MGD MGI:1913277
Others CRBN NCBI
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z